Your search
Results 2 resources
-
Diabetes is one of the leading fatal diseases globally, putting a huge burden on the global healthcare system. Early diagnosis of diabetes is hence, of utmost importance and could save many lives. However, current techniques to determine whether a person has diabetes or has the risk of developing diabetes are primarily reliant upon clinical biomarkers. In this article, we propose a novel deep learning architecture to predict if a person has diabetes or not from a photograph of his/her retina. Using a relatively small-sized dataset, we develop a multi-stage convolutional neural network (CNN)-based model DiaNet that can reach an accuracy level of over 84% on this task, and in doing so, successfully identifies the regions on the retina images that contribute to its decision-making process, as corroborated by the medical experts in the field. This is the first study that highlights the distinguishing capability of the retinal images for diabetes patients in the Qatari population to the best of our knowledge. Comparing the performance of DiaNet against the existing clinical data-based machine learning models, we conclude that the retinal images contain sufficient information to distinguish the Qatari diabetes cohort from the control group. In addition, our study reveals that retinal images may contain prognosis markers for diabetes and other comorbidities like hypertension and ischemic heart disease. The results led us to believe that the inclusion of retinal images into the clinical setup for the diagnosis of diabetes is warranted in the near future.
-
Cardiovascular disease (CVD) is reported to be the leading cause of mortality in the middle eastern countries, including Qatar. But no comprehensive study has been conducted on the Qatar specific CVD risk factors identification. The objective of this case-control study was to develop machine learning (ML) model distinguishing healthy individuals from people having CVD, which could ultimately reveal the list of potential risk factors associated to CVD in Qatar. To the best of our knowledge, this study considered the largest collection of biomedical measurements representing the anthropometric measurements, clinical biomarkers, bioimpedance, spirometry, VICORDER readings, and behavioral factors of the CVD group from Qatar Biobank (QBB). CatBoost model achieved 93% accuracy, thereby outperforming the existing model for the same purpose. Interestingly, combining multimodal datasets into the proposed ML model outperformed the ML model built upon currently known risk factors for CVD, emphasizing the importance of incorporating other clinical biomarkers into consideration for CVD diagnosis plan. The ablation study on the multimodal dataset from QBB revealed that physio-clinical and bioimpedance measurements have the most distinguishing power to classify these two groups irrespective of gender and age of the participants. Multiple feature subset selection techniques confirmed known CVD risk factors (blood pressure, lipid profile, smoking, sedentary life, and diabetes), and identified potential novel risk factors linked to CVD-related comorbidities such as renal disorder (e.g., creatinine, uric acid, homocysteine, albumin), atherosclerosis (intima media thickness), hypercoagulable state (fibrinogen), and liver function (e.g., alkaline phosphate, gamma-glutamyl transferase). Moreover, the inclusion of the proposed novel factors into the ML model provides better performance than the model with traditional known risk factors for CVD. The association of the proposed risk factors and comorbidities are required to be investigated in clinical setup to understand their role in CVD better. © 2013 IEEE.